The COVID-19 pandemic has affected students in different ways. Some districts have been closed while others have been affected only slightly. Some districts have lost internet coverage, and others aren't at all connected at all. Others don't even have 3G coverage, or have very poor internet connections. Regardless of the causes, students are suffering because of the pandemic.
Adolescent Behaviors and Experiences Survey (ABES):
Researchers at the Centers for Disease Control and Prevention (CDC) recently released the results of the Adolescent Behaviors and Experiences Study (ABES), a one-time online survey of 7,998 high school students. This survey evaluated how the COVID-19 pandemic affected students and their studies. They also studied the effects of the disease on students' mental health and climate in their school district.
The CDC's Adolescent Behaviors and Experiences Study (ABES) includes a measure of perceived racism that examines the attitudes of adolescents about racial differences. The survey, conducted by the Centers for Disease Control and Prevention (CDC), is a nationally representative sample of high school students.
The Adolescent Behaviors and Experiences Study has found that girls were more likely to report feeling low after undergoing the COVID-19 outbreak than boys. Girls were also more likely to report having a negative experience in the 30 days before completing the survey. The study concludes that this pandemic has affected the students' studies and mental health.
The results of this survey also highlight the importance of addressing student mental health. The survey showed that students who identify as LGB experienced disproportionately high rates of mental health and suicide-related behaviors than their heterosexual counterparts. Nearly 20 per cent of LGB high school students reported having attempted suicide in the past year, compared to just 5% of heterosexual or monosexual students.
Impact of COVID-19 testing on students:
The American Rescue Plan, passed by Congress in December 2017, has allocated $200 billion for public schools to address the challenges of COVID-19. Of that, $22 billion will go towards addressing learning loss, evidence-based interventions, and the disproportionate impact of COVID-19 on underrepresented student groups. However, concerns about the impact of COVID-19 testing have remained. A USC study shows that school administrators should be aware of these concerns and consider reopening schools as part of their reopening plans.
In addition to the study's findings, it revealed that COVID-19 testing in Connecticut is generally consistent. Some schools increased testing volume on move-in day and during outbreaks. Albertus Magnus College increased its testing volume in spring 2021. Four other institutions increased testing volume during the initial quarantine period. On average, schools tested 75% of students weekly in the spring; however, only 4 schools consistently tested students twice a week.
The primary inclusion criteria for studies in this review included actual data, statistical analyses, and effect sizes. The study also emphasized studies that incorporated student achievement as a dependent variable. The review excluded studies that were only reviews of the COVID-19 testing or exploratory analyses. Furthermore, it excluded studies that reported only percentages. However, the results of the systematic review can serve as a benchmark for future studies.
Impact of school closures on student achievement:
This study sought to identify three moderating factors for the effect of school closings caused by the COVID-19 pandemic on student achievement. The moderating factors include the type of school, the mode of learning, and the timing of school closures. The first variable provides the first indication of whether COVID-19 school closures lead to changes in student achievement.
Despite the negative effects of school closings on individual learning, most scholars agree that children will spend less time in school and more time at home. The prolonged social isolation of students may worsen their mental health outcomes. In addition, children may be deprived of educational resources and thus suffer fewer opportunities to complete assignments and other tasks. This would further exacerbate the socioeconomic gap between high and low-income students.
Author Bio:
Carmen Troy is a research-based content writer for Essays.UK, The most trusted and Best Essay Writing services in UK. They have expert Essay writers, and they provide the Best Literature review writing service. Carmen Troy is also working for the Research Prospect. They have expert Essay writers in the UK and provide Professional Research Proposal Help, Dissertation writing services in the UK and also provide the Best Essay writing service in UK and many more services to students of all levels. Their experts are all UK-qualified. Mr Carmen holds a PhD degree in mass communication. He loves expressing his views on various issues, including education, technology, etc.
April 26th every year marks the celebration of World Intellectual Property Day or World IP Day, and its theme for this year is “Innovate for a Green Future.https://www.kashishworld.com/blog/how-can-ip-be-a-solution-in-situations-of-crisis-like-the-covid-19-pandemic/
Coronavirus knocked on our doors and the first thing that saw its adverse effect was our corporate offices.
People started falling ill and dropping out of offices.
Lockdown was initiated and many people had to leave work.
But is that a long-term solution?Nope!By cleaning and keeping your office spotless you will just acquire an aesthetic beauty but what about infections.
For that, we need to take certain steps to make our offices germ-proof.
Here, are some of the best ways to help you with keeping your workplace employee-friendly.
The COVID19 times have taught us many things and the remote work culture comes with a new experience.
So, make the most of this time by making efficient use of these tools.
Pick your favorite and get started!
According to the new market research report “COVID-19 impact on Medical Supplies Market by Type (Intubations, Personal Protective Equipment, Infusion, Radiology, Wound Care Supplies), End User (Hospitals, Clinics) – Global Forecast” published by MarketsandMarkets™.Revenue Growth Opportunities and Growth Drivers?The COVID-19 impact on the global medical supplies market is expected to reach USD ~100 billion by 2021 from an estimated value of USD ~78 billion in 2019, growing at a CAGR of ~13.4% during the forecast period.Growth Boosting Factors:Growing awareness for environmental & personal hygiene leading to rising demand of disinfectantsIncreasing number of emergency centers, hospital settings and ICUs during the PandemicIncreasing need of healthcare workers in hospitals and government camps & surveysIncreased demand of PPE kits and n95 masks globallyIncreasing demand of ventilation supplies for effective management of critical COVID-19 patientsIncreasing demand of diagnostic supplies for rapid diagnosis of COVID-19Browse 97 market data Tables and 20 Figures spread through 150 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158189339Market Segmentation in Detailed:Based on type, the medical supplies market is segmented into intubation and ventilation supplies, disinfectant, personal protective equipment, diagnostic supplies, sterilization supplies, infusion and injectable supplies, dialysis supplies, wound care supplies, radiology supplies, and other medical supplies.
The disinfectant segment is expected to grow at the highest CAGR during the forecast period.Based on end users, the market is segmented into hospitals, clinics, and other end-users.
The hospital segment is expected to grow at the highest CAGR owing to increasing demand for hospital beds and intensive care units in countries with the increasing incidence of COVID-19, increasing demand for specialized staff such as infectious disease experts providers, respiratory therapists, and physicians and nurses who can provide intensive and critical care, increased consumption of personnel protective equipment within the hospital premises; and the increasing support from government and non-government organization to combat with COVID-19 are the major factors driving the demand and uptake of medical supplies in hospitals growth.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158189339North America accounted for the largest share of the medical supplies market in 2020, followed by Europe.
The large share of this region is attributed mainly to a high number of positive COVID-19 cases and deaths in the US, a strong healthcare system, and the presence of many large hospitals.
Moreover, a large number of major global players are based in the US, owing to which the US can easily manufacture these devices.The prominent players in the medical supplies market are Medtronic plc (Ireland), Cardinal Health, Inc. (US), Becton, Dickson and Company (US), Johnson & Johnson (US), and B. Braun Melsungen AG (Germany), Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), STERIS Corporation (US), Getinge Group (Sweden), Advanced Sterilization Products (US), 3M Company (US), Smith & Nephew (U.K.), Mölnlycke Health Care AB (Sweden), among others.
In the latest coronavirus vaccine latest update, the US-based biotech company Moderna released new data on Monday which conclusively strengthens its case for the covid-19 vaccine.
The study stated that the moderna vaccine is 94% effective, and causes the human immune system to produce potent antibodies that endure for at least three months.Moderna Inc said that it expects between 100 million to 125 million doses of its experimental covid-19 vaccine available globally in the first quarter of 2021, in this latest covid-19 vaccine update USA.
The company added that around 85 million to 100 million of those doses would be available in the United States, while 15 million to 25 million available outside the country.The first-quarter doses are within the 500 million to up to 1 billion doses the company expects to manufacture in 2021, as per the covid-19 vaccine tracker.The vaccine, mRNA-1273, achieved high levels of binding and neutralizing antibodies in its test subjects.
Although these high levels of antibodies produced due to this covid-19 vaccine declined slightly over time, by introducing a booster vaccination the levels could be maintained high, for up to three months in all participants.The COVID-19 vaccine race:The Moderna vaccine built on the company’s previously reported findings, based on its study of about 30,000 volunteers.
In the study where both placebo and active shots were given to volunteers, only 11 of the active volunteers reported cases as opposed to the 185 cases in the placebo team.In other covid-19 vaccine news – Pfizer, which has developed a similar vaccine, reported similar findings.
Both Moderna and Pfizer vaccine showed promise in preventing severe cases.Based on these findings and the analysis of the vaccine’s safety and side-effects, Moderna has submitted an application for emergency use authorization to the food and drug administration(FDA).Pfizer applied for the same for its covid-19 vaccine on November 9.
